Inocras
1 known investors
Inocras provides whole genome sequencing tests and analysis for cancer profiling, minimal residual disease detection via ctDNA, and diagnosis of rare diseases. It combines sequencing technologies with AI and bioinformatics to deliver genomic insights for patients, clinicians, and researchers.
AI & Machine LearningBiotechHealthtech
Investors · 1
Frequently asked questions
- What does Inocras do?
- Inocras provides whole genome sequencing tests and analysis for cancer profiling, minimal residual disease detection via ctDNA, and diagnosis of rare diseases. It combines sequencing technologies with AI and bioinformatics to deliver genomic insights for patients, clinicians, and researchers.
- Who are Inocras's investors?
- Inocras's investors include Dunamu & Partners.